BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

With the growing trend of heavier cattle and carcass weights, packers are seeing higher rates of bovine congestive heart ...

Heart disease and breast cancer are two of the most significant health threats facing Black women today. Here's ...

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Coronary heart disease is a condition that occurs when the blood vessels that supply oxygen-rich blood to the heart muscle ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular disease remains a leading cause of death and disability worldwide. Heart failure (HF) is ...

Eli Lilly CEO confirms oral obesity drug Phase 3 results expected in Q2 Eli Lillys CEO updates on drug trials amid mixed ...

TUGUEGARAO CITY, Cagayan (PIA) — PhilHealth has expanded its benefit package for the treatment of ischemic heart disease or acute myocardial infarction, commonly known as heart attack, one of the ...

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee ...

The $90m will be used to launch the second of two pivotal trials examining the company’s therapy for patients living with heart failure.